Editorial: Cancer genomics in the era of precision medicine

Omar M Khan; Domenico Mallardo; Julie Decock

doi:10.3389/fgene.2024.1378917

Editorial: Cancer genomics in the era of precision medicine

Front Genet. 2024 Feb 16:15:1378917. doi: 10.3389/fgene.2024.1378917. eCollection 2024.

Authors

Omar M Khan¹, Domenico Mallardo², Julie Decock^{1

3}

Affiliations

¹ College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
² Department of Melanoma, Cancer Immunotherapy and Development Therapeutics INT IRCCS Fondazione "G Pascale", Napoli, Italy.
³ Cancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.

No abstract available

Keywords: biomarkers; cancer genomics; diagnostics; epigenetics; precision medicine; predictive value.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by a grant from the Qatar Biomedical Research Institute (IGP-VR94-2020), awarded to JD and OMK is supported by an intramural grant from the College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar (CHLS, HBKU).